<DOC>
	<DOCNO>NCT02600364</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness p64 Flow Modulation Device .</brief_summary>
	<brief_title>Diversion-p64 Post Market Clinical Follow-Up Study Assess Safety Effectiveness p64 Flow Modulation Device</brief_title>
	<detailed_description>Title : Diversion-p64 . Device : p64 Flow Modulation Device . Study design : Prospective , multicenter , single arm Post Market Clinical Follow-Up Study . Purpose : To assess safety effectiveness p64 . Study duration : 30 month . Sample Size : 107 patient . Number sit : 20 . Follow-up interval : 3-6 12 month clinical angiographic follow-up .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>1 . Age â‰¥ 18 2 . Patient harbour either saccular dissecting blisterlike fusiform intracerebral aneurysm intracerebral segmental disease , anterior circulation indication p64 treatment give 3 . Patient legal representative provide write informed consent verify he/she consent use his/her data ( accord data protection law ) 1 . Aneurysms posterior circulation 2 . Imaging evidence bifurcation aneurysm 3 . Imaging evidence dissection 4 . Imaging evidence fistulae 5 . Imaging evidence arteriovenous malformation 6 . Patient harbour another aneurysm treat within six month first procedure 7 . Known allergy study medication , e.g . ASA , Clopidogrel , Heparin contrast medium 8 . Pregnant breast feed woman woman childbearing potential provide negative pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Aneurysm</keyword>
	<keyword>intracerebral</keyword>
	<keyword>stroke</keyword>
	<keyword>p64</keyword>
</DOC>